NCT04315181View on ClinicalTrials.gov

Prescription Medication Interactions

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

March 25, 2019

Primary Completion Date

May 6, 2023

Study Completion Date

May 6, 2023

Conditions
Opioid UseSedative Use
Interventions
DRUG

Opioid Agonist

Abuse liability evaluation.

DRUG

Sedatives

Abuse liability evaluation.

Trial Locations (1)

40508

Center on Drug and Alcohol Research, Lexington

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Sharon Walsh

OTHER

NCT04315181 - Prescription Medication Interactions | Biotech Hunter | Biotech Hunter